| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |